Center for Biobehavioral Health, The Abigail Wexner Research Institute, Columbus, Ohio; The Ohio State University College of Medicine, Columbus, Ohio.
Center for Biobehavioral Health, The Abigail Wexner Research Institute, Columbus, Ohio.
J Adolesc Health. 2023 Jun;72(6):860-868. doi: 10.1016/j.jadohealth.2023.01.031. Epub 2023 Apr 6.
We aimed to examine the concurrent associations of gender-affirming hormonal interventions (i.e., puberty blockers, testosterone, estrogen), as well as family and friend social support, on transgender and nonbinary (TNB) adolescents' reports of anxiety symptoms, depressive symptoms, nonsuicidal self-injury (NSSI), and suicidality. We hypothesized that gender-affirming hormonal interventions and greater social support would be associated with lower levels of mental health concerns.
Participants (n = 75; aged 11-18; M = 16.39 years) were recruited for this cross-sectional study from a gender-affirming multidisciplinary clinic. Fifty-two percent were receiving gender-affirming hormonal interventions. Surveys assessed anxiety and depressive symptoms, NSSI and suicidality in the past year, and social support from family, friends, and significant others. Hierarchical linear regression models examined associations between gender-affirming hormonal interventions and social support (i.e., family, friend) with mental health while accounting for nonbinary gender identity.
Regression models explained 15%-23% of variance in TNB adolescents' mental health outcomes. Gender-affirming hormonal interventions were associated with fewer anxiety symptoms (β = -0.23; p < .05). Family support was associated with fewer depressive symptoms (β = -0.33; p = .003) and less NSSI (β = -0.27; p = .02). Friend support was associated with fewer anxiety symptoms (β = -0.32; p = .007) and less suicidality (β = -0.25; p = .03).
TNB adolescents had better mental health outcomes in the context of receiving gender-affirming hormonal interventions and having greater support from family and friends. Findings highlight the important role of quality family and friend support for TNB mental health. Providers should aim to address both medical and social factors to optimize TNB mental health outcomes.
本研究旨在考察性别肯定性激素干预(即青春期阻滞剂、睾丸素、雌激素)以及家庭和朋友社会支持与跨性别和非二元性别(TNB)青少年焦虑症状、抑郁症状、非自杀性自伤(NSSI)和自杀意念报告之间的并发关联。我们假设性别肯定性激素干预和更多的社会支持与较低的心理健康问题有关。
本横断面研究从一个性别肯定性多学科诊所招募了 75 名参与者(年龄 11-18 岁;M=16.39 岁)。其中 52%的人正在接受性别肯定性激素干预。调查评估了过去一年的焦虑和抑郁症状、NSSI 和自杀意念,以及来自家庭、朋友和重要他人的社会支持。分层线性回归模型考察了性别肯定性激素干预和社会支持(即家庭、朋友)与心理健康之间的关联,同时考虑了非二元性别认同。
回归模型解释了 TNB 青少年心理健康结果的 15%-23%的方差。性别肯定性激素干预与较少的焦虑症状相关(β=-0.23;p<.05)。家庭支持与较少的抑郁症状相关(β=-0.33;p=.003)和较少的 NSSI 相关(β=-0.27;p=.02)。朋友支持与较少的焦虑症状相关(β=-0.32;p=.007)和较少的自杀意念相关(β=-0.25;p=.03)。
在接受性别肯定性激素干预和获得家庭和朋友更多支持的情况下,TNB 青少年有更好的心理健康结果。这些发现强调了高质量的家庭和朋友支持对 TNB 心理健康的重要作用。提供者应旨在解决医疗和社会因素,以优化 TNB 心理健康结果。